The U.S. winter virus season is in full force, and by one measure is the most intense in 15 years. One indicator of flu ...

With data showing a significant rise in flu cases nationwide, medical experts are describing it as the worst flu season since ...

Pennsylvania National Electronic Disease Surveillance System. Influenza activity is high across the state and has increased ...

In addition to the cold and flu, many are falling ill to RSV, COVID and norovirus this winter. How to know what you have.

FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.

For the week ending Jan. 25, seasonal flu activity remains high and increasing. Clinical laboratories tested 129,378 ...

2 While often linked to infants and young children, RSV poses an even greater risk to older adults due to age and underlying health conditions, potentially leading to severe respiratory illness.

Abrysvo was first approved on May 31, 2023, for prevention of lower respiratory tract disease (LRTD) associated with RSV in adults aged 60 years or more, and has since been approved for the same ...

GSK will start preparations for regulatory filings of its respiratory syncytial virus (RSV) vaccine straight away, after the shot hit the mark in the much-anticipated AReSVi 006 trial in adults ...